{"transactions":[{"id":1496561,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Performance Stock Unit","published_at":"2024-05-31T16:24:59.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU subject to performance-based vesting conditions (\"PSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such PSU (assuming attainment of (A) the actual level of performance for performance metrics for which the relevant performance period had been completed as of the Effective Time and (B) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period had not been completed as of the Effective Time) and (ii) the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) The amount reported represents PSUs for which performance was deemed achieved assuming attainment of maximum level of performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU subject to performance-based vesting conditions (\"PSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such PSU (assuming attainment of (A) the actual level of performance for performance metrics for which the relevant performance period had been completed as of the Effective Time and (B) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period had not been completed as of the Effective Time) and (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from Footnote 4) The amount reported represents PSUs for which performance was deemed achieved assuming attainment of maximum level of performance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU subject to performance-based vesting conditions (\"PSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such PSU (assuming attainment of (A) the actual level of performance for performance metrics for which the relevant performance period had been completed as of the Effective Time and (B) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period had not been completed as of the Effective Time) and (ii) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"(Continued from Footnote 4) The amount reported represents PSUs for which performance was deemed achieved assuming attainment of maximum level of performance."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100810},"source":{"system":"sec-edgar","filing":"0001642545-24-000110","document":"wk-form4_1717187088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000110/wk-form4_1717187088.xml","form_type":"4"}},{"id":1496560,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-05-31T16:24:59.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001642545-24-000110","document":"wk-form4_1717187088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000110/wk-form4_1717187088.xml","form_type":"4"}},{"id":1496559,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-05-31T16:24:59.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":294799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":294799},"source":{"system":"sec-edgar","filing":"0001642545-24-000110","document":"wk-form4_1717187088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000110/wk-form4_1717187088.xml","form_type":"4"}},{"id":1496558,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-31T16:24:59.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":151629,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson (\"J&J\"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of the effective time of the Merger (the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer (\"Common Stock\") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the \"Merger Consideration\"),"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) without interest and less any applicable withholding taxes.  Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit (\"RSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001642545-24-000110","document":"wk-form4_1717187088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000110/wk-form4_1717187088.xml","form_type":"4"}},{"id":1527874,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-03T19:53:54.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":552,"price":329.81,"value":182055.12,"ownership":{"direct":true},"balance_after":151629,"source":{"system":"sec-edgar","filing":"0001642545-24-000086","document":"wk-form4_1714780424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000086/wk-form4_1714780424.xml","form_type":"4"}},{"id":1527873,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-03T19:53:54.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":592,"price":329.81,"value":195247.52,"ownership":{"direct":true},"balance_after":152181,"source":{"system":"sec-edgar","filing":"0001642545-24-000086","document":"wk-form4_1714780424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000086/wk-form4_1714780424.xml","form_type":"4"}},{"id":1628862,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-21T20:52:54.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9989,"price":255.67,"value":2553887.63,"ownership":{"direct":true},"balance_after":152773,"source":{"system":"sec-edgar","filing":"0001642545-24-000048","document":"wk-form4_1708566763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000048/wk-form4_1708566763.xml","form_type":"4"}},{"id":1638061,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully vested."}],"balance_after":294799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638060,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":831,"price":236.13,"value":196224.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $235.99 to $236.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":162762,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638059,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":600,"price":235.21,"value":141126.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $234.91 to $235.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":163593,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638058,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":233.54,"value":46708.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"All reported securities were sold at a price of $233.54."}],"balance_after":164193,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638057,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":792,"price":232.74,"value":184330.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $232.37 to $233.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":164393,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638056,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":1987,"price":231.74,"value":460467.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.35 to $232.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":165185,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638055,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":230.86,"value":646408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.32 to $231.24. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":167172,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638054,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":2230,"price":229.82,"value":512498.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $230.08. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":169972,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638053,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":560,"price":228.28,"value":127836.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $227.95 to $228.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":172202,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1638052,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-16T20:02:20.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.416,"value":34160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023."}],"balance_after":172762,"source":{"system":"sec-edgar","filing":"0001642545-24-000044","document":"wk-form4_1708131730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000044/wk-form4_1708131730.xml","form_type":"4"}},{"id":1656693,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-06T20:12:59.000Z","date":"2024-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":604,"price":226.3,"value":136685.2,"ownership":{"direct":true},"balance_after":162762,"source":{"system":"sec-edgar","filing":"0001642545-24-000036","document":"wk-form4_1707268368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000036/wk-form4_1707268368.xml","form_type":"4"}},{"id":1656692,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-06T20:12:59.000Z","date":"2024-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2614,"price":226.28,"value":591495.92,"ownership":{"direct":true},"balance_after":163366,"source":{"system":"sec-edgar","filing":"0001642545-24-000036","document":"wk-form4_1707268368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000036/wk-form4_1707268368.xml","form_type":"4"}},{"id":1656691,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-06T20:12:59.000Z","date":"2024-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":5918,"price":226.3,"value":1339243.4,"ownership":{"direct":true},"balance_after":165980,"source":{"system":"sec-edgar","filing":"0001642545-24-000036","document":"wk-form4_1707268368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000036/wk-form4_1707268368.xml","form_type":"4"}},{"id":1661429,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-02T20:06:48.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":19013,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":171898,"source":{"system":"sec-edgar","filing":"0001642545-24-000024","document":"wk-form4_1706922390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000024/wk-form4_1706922390.xml","form_type":"4"}},{"id":1676214,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested."}],"balance_after":304799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676213,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-18","kind":"tax_withholding","planned":true,"acquired":false,"shares":10250,"price":217.78,"value":2232245.0,"ownership":{"direct":true},"balance_after":152885,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676212,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-17","kind":"grant","planned":true,"acquired":true,"shares":22078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents the vesting and settlement of a performance-based restricted stock unit award granted on February 1, 2022, resulting from the achievement of certain performance criteria related to the compound annual growth rate of the Issuers revenue during the measurement period January 1, 2022 through December 31, 2023."}],"balance_after":163135,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676211,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":220,"value":220000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.79 to $220.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141057,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676210,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":1248,"price":219.27,"value":273648.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $218.70 to $219.58. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":142057,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676209,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":1302,"price":217.97,"value":283796.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $217.49 to $218.43. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":143305,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676208,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":6150,"price":216.87,"value":1333750.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $216.47 to $217.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":144607,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676207,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":300,"price":215.54,"value":64662.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $215.23 to $216.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":150757,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1676206,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-18T20:15:25.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.416,"value":34160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":151057,"source":{"system":"sec-edgar","filing":"0001642545-24-000012","document":"wk-form4_1705626913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000012/wk-form4_1705626913.xml","form_type":"4"}},{"id":1684059,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-01-08T20:18:57.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":314799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001642545-24-000004","document":"wk-form4_1704763128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000004/wk-form4_1704763128.xml","form_type":"4"}},{"id":1684058,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-08T20:18:57.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":200.05,"value":2000500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $200.00 to $200.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141057,"source":{"system":"sec-edgar","filing":"0001642545-24-000004","document":"wk-form4_1704763128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000004/wk-form4_1704763128.xml","form_type":"4"}},{"id":1684057,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-08T20:18:57.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.416,"value":34160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":151057,"source":{"system":"sec-edgar","filing":"0001642545-24-000004","document":"wk-form4_1704763128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254524000004/wk-form4_1704763128.xml","form_type":"4"}},{"id":1706971,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":324799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1706970,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":191.03,"value":38206.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $191.00 to $191.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141057,"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1706969,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":359,"price":190.03,"value":68220.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $189.98 to $190.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141257,"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1706968,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":700,"price":188.47,"value":131929.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $188.25 to $189.01. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141616,"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1706967,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":2293,"price":187.56,"value":430075.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $187.24 to $188.08. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":142316,"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1706966,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":1448,"price":186.84,"value":270544.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $186.24 to $187.22. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":144609,"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1706965,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-18T20:09:29.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":3.416,"value":17080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":146057,"source":{"system":"sec-edgar","filing":"0001642545-23-000053","document":"wk-form4_1702948159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000164254523000053/wk-form4_1702948159.xml","form_type":"4"}},{"id":1732484,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-21T20:20:55.000Z","date":"2022-04-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1887,"price":177.35,"value":334659.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $177.35."}],"balance_after":142926,"source":{"system":"sec-edgar","filing":"0001209191-23-056402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123056402/doc4.xml","form_type":"4"}},{"id":1736465,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments."}],"balance_after":329799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736464,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":3.416,"value":17080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":141057,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736463,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":400,"price":177.02,"value":70808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from\n$176.65 to $177.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":136057,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736462,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":914,"price":175.82,"value":160699.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from\n$175.48 to $176.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":136457,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736461,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":1186,"price":175.11,"value":207680.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from\n$174.48 to $175.43. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":137371,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736460,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":500,"price":173.93,"value":86965.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from\n$173.44 to $174.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":138557,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736459,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":900,"price":172.82,"value":155538.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from\n$172.30 to $173.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":139057,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1736458,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-17T20:00:52.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":171.56,"value":188716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from\n$171.16 to $172.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":139957,"source":{"system":"sec-edgar","filing":"0001209191-23-055916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055916/doc4.xml","form_type":"4"}},{"id":1740547,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-15T20:14:26.000Z","date":"2023-11-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":592,"price":214.07,"value":126729.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $214.07."}],"balance_after":141057,"source":{"system":"sec-edgar","filing":"0001209191-23-055435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123055435/doc4.xml","form_type":"4"}},{"id":1758928,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments."}],"balance_after":334799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758927,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":1846,"price":203.6,"value":375845.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $203.22 to $204.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141649,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758926,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":1254,"price":202.86,"value":254386.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $202.21 to $203.14. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":143495,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758925,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":300,"price":201.29,"value":60387.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $200.87 to $201.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":144749,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758924,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":200,"value":1100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $199.63 to $200.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":145049,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758923,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":600,"price":198.64,"value":119184.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $198.35 to $199.01. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":150549,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758922,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":300,"price":197,"value":59100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $196.93 to $197.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":151149,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758921,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":200,"price":194.59,"value":38918.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All reported securities were sold at a price of $194.59."}],"balance_after":151449,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1758920,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-17T20:10:36.000Z","date":"2023-10-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.416,"value":34160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":151649,"source":{"system":"sec-edgar","filing":"0001209191-23-053035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123053035/doc4.xml","form_type":"4"}},{"id":1777196,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments."}],"balance_after":344799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1777195,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":500,"price":214.52,"value":107260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $214.49 to $214.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141649,"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1777194,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":4871,"price":213.65,"value":1040689.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $213.30 to $214.28. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":142149,"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1777193,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":2086,"price":212.74,"value":443775.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.27 to $213.21. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":147020,"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1777192,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":1343,"price":211.79,"value":284433.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $211.25 to $212.08. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":149106,"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1777191,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":210.38,"value":252456.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.12 to $210.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":150449,"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1777190,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-19T20:10:07.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.416,"value":34160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":151649,"source":{"system":"sec-edgar","filing":"0001209191-23-050098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123050098/doc4.xml","form_type":"4"}},{"id":1796266,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments."}],"balance_after":354799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796265,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":500,"price":222.61,"value":111305.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $222.56 to $222.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141649,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796264,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":1707,"price":221.56,"value":378202.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $221.17 to $221.93. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":142149,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796263,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":2204,"price":220.5,"value":485982.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $220.05 to $221.03. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":143856,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796262,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":1204,"price":219.6,"value":264398.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.05 to $220.03. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":146060,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796261,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":303,"price":213.15,"value":64584.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $213.08 to $213.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":147264,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796260,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":199,"price":211.29,"value":42046.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $211.19 to $211.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":147567,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796259,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":505,"price":209.16,"value":105625.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $208.79 to $209.36. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":147766,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796258,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":600,"price":207.8,"value":124680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.39 to $208.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":148271,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796257,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":300,"price":206.68,"value":62004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $206.29 to $207.28. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":148871,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796256,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":700,"price":205.7,"value":143990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.12 to $206.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":149171,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796255,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":1778,"price":204.36,"value":363352.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $203.94 to $204.84. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":149871,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1796254,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-25T20:09:25.000Z","date":"2023-08-24","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.416,"value":34160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023."}],"balance_after":151649,"source":{"system":"sec-edgar","filing":"0001209191-23-047457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123047457/doc4.xml","form_type":"4"}},{"id":1814816,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-04T20:01:48.000Z","date":"2023-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":614,"price":250.1,"value":153561.4,"ownership":{"direct":true},"balance_after":141649,"source":{"system":"sec-edgar","filing":"0001209191-23-044688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123044688/doc4.xml","form_type":"4"}},{"id":1902438,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-05-05T20:10:47.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":610,"price":280.76,"value":171263.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $280.76."}],"balance_after":142263,"source":{"system":"sec-edgar","filing":"0001209191-23-027843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123027843/doc4.xml","form_type":"4"}},{"id":1913283,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-04-26T20:03:30.000Z","date":"2023-04-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1868,"price":280.01,"value":523058.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $280.01."}],"balance_after":142873,"source":{"system":"sec-edgar","filing":"0001209191-23-025757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123025757/doc4.xml","form_type":"4"}},{"id":1999560,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments."}],"balance_after":364799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999559,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":30000,"price":3.416,"value":102480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."}],"balance_after":144741,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999558,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":400,"price":194.17,"value":77668.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $193.95 to $194.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":114741,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999557,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":1853,"price":193.1,"value":357814.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $192.71 to $193.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":115141,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999556,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":1700,"price":192.19,"value":326723.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $191.70 to $192.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":116994,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999555,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":1300,"price":190.92,"value":248196.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $190.67 to $191.47. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":118694,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999554,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":1100,"price":190,"value":209000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $189.57 to $190.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":119994,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999553,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":2300,"price":188.85,"value":434355.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $188.37 to $189.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":121094,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999552,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":9042,"price":187.79,"value":1697997.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $187.37 to $188.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":123394,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999551,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":4087,"price":186.86,"value":763696.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $186.37 to $187.36. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":132436,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999550,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":3518,"price":186.02,"value":654418.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $185.37 to $186.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":136523,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999549,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":1700,"price":184.71,"value":314007.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $184.31 to $185.24. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":140041,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999548,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":2600,"price":183.93,"value":478218.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $183.28 to $184.27. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":141741,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999547,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":400,"price":182.68,"value":73072.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $182.27 to $183.13. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":144341,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":1999546,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-22T20:17:49.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":10053,"price":192.88,"value":1939022.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $192.88."}],"balance_after":144741,"source":{"system":"sec-edgar","filing":"0001209191-23-012014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123012014/doc4.xml","form_type":"4"}},{"id":2032683,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-03T20:48:59.000Z","date":"2023-02-02","kind":"tax_withholding","acquired":false,"shares":8486,"price":188.26,"value":1597574.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $188.27 to $188.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":154794,"source":{"system":"sec-edgar","filing":"0001209191-23-007195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123007195/doc4.xml","form_type":"4"}},{"id":2032682,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-03T20:48:59.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":20354,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":163280,"source":{"system":"sec-edgar","filing":"0001209191-23-007195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919123007195/doc4.xml","form_type":"4"}},{"id":2098043,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":90381,"kind":"person","name":"Godshall Douglas Evan","position":1,"cik":"0001404227","reported_name":"Godshall Douglas Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2022-12-02T20:19:51.000Z","date":"2022-11-14","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments."}],"balance_after":394799,"derivative":{"exercise_price":3.416,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-059519","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404227/000120919122059519/doc4a.xml","form_type":"4/A","original_submission_date":"2022-11-16"}}],"next_cursor":"2022-12-02T20:19:51.000000Z,2098043"}